Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
3(38%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
13%
Ph phase_2
3
38%
Ph not_applicable
1
13%
Ph phase_4
3
38%

Phase Distribution

1

Early Stage

3

Mid Stage

3

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
3(37.5%)
Phase 4Post-market surveillance
3(37.5%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(6)
Completed(1)
Other(1)

Detailed Status

Not yet recruiting3
Recruiting3
unknown1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (12.5%)
Phase 23 (37.5%)
Phase 43 (37.5%)
N/A1 (12.5%)

Trials by Status

not_yet_recruiting338%
recruiting338%
unknown113%
completed113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8